Preclinical News and Research

RSS
Nuclear reactor as a cancer cure

Nuclear reactor as a cancer cure

Middle-aged women who take an active role in their health care may be less likely to develop cardiovascular disease

Middle-aged women who take an active role in their health care may be less likely to develop cardiovascular disease

Genzyme begins gene transfer trial for peripheral arterial disease

Genzyme begins gene transfer trial for peripheral arterial disease

Pfizer acquires Idun Pharmaceuticals

Pfizer acquires Idun Pharmaceuticals

Is it exercise or dieting that helps prevent cancer?

Is it exercise or dieting that helps prevent cancer?

Lack of early market research spending lowers drug success rates

Lack of early market research spending lowers drug success rates

Government grant pumps Vascam`s commercialisation

Government grant pumps Vascam`s commercialisation

2.5 million euros helps fight liver cancer

2.5 million euros helps fight liver cancer

Benitec announces AIDS collaboration

Benitec announces AIDS collaboration

Novel approach to treating hearing loss

Novel approach to treating hearing loss

Renovis announces investigational medicine for multiple sclerosis study

Renovis announces investigational medicine for multiple sclerosis study

New compound AMN107 may help treat some imatinib resistant cancer cases

New compound AMN107 may help treat some imatinib resistant cancer cases

Solbec announces pre-clinical study to confirm findings into the effect of Coramsine combined with CpG in the treatment of murine mesothelioma

Solbec announces pre-clinical study to confirm findings into the effect of Coramsine combined with CpG in the treatment of murine mesothelioma

Nicotine may hold promise in the early diagnosis of Alzheimer's disease

Nicotine may hold promise in the early diagnosis of Alzheimer's disease

New method of delivery of gene therapy may lead to safer treatment for cancer

New method of delivery of gene therapy may lead to safer treatment for cancer

Research breakthrough in treatment of TB and MDR-TB

Research breakthrough in treatment of TB and MDR-TB

Myriad Genetics initiates phase 3 clinical trial of Flurizan

Myriad Genetics initiates phase 3 clinical trial of Flurizan

Escalating demand for novel and effective therapeutic approaches underlines growing appeal of peptides

Escalating demand for novel and effective therapeutic approaches underlines growing appeal of peptides

Recent study correlates human cord blood cells with reduced animal heart attack damage

Recent study correlates human cord blood cells with reduced animal heart attack damage

Potential new therapies for cancer and bleeding disorders

Potential new therapies for cancer and bleeding disorders